Therapeutic Promises of Chlorogenic Acid with Special Emphasis on its Anti-Obesity Property

Curr Mol Pharmacol. 2020;13(1):7-16. doi: 10.2174/1874467212666190716145210.

Abstract

Background: Chlorogenic acid (CGA) is a quinic acid conjugate of caffeic acid. It is an ester formed between caffeic acid and the 3-hydroxyl of L-quinic acid. This polyphenol is naturally present in substantial amount in the green coffee beans. Minor quantities of CGA are also reported in apples, eggplant, blueberries, tomatoes, strawberries and potatoes. CGA is reported to be beneficial in hypertension, hyperglycemia, antimicrobial, antitumor, memory enhancer, weight management etc. Further, it is also reported to have anticancer, antioxidant and anti-inflammatory activities. Since the last decade, CGA drew public attention for its widely recommended use as a medicine or natural food additive supplement for the management of obesity.

Objective: The current review explores the medicinal promises of CGA and emphasizes on its antiobese property as reported by various scientific reports and publication.

Conclusion: CGA shows promises as an antioxidant, glycemic control agent, anti-hypertensive, antiinflammatory, antimicrobial, neuro-protective and anti-obesity agent. It primarily activates the AMPactivated protein kinase, inhibits 3-hydroxy 3-methylglutaryl coenzyme-A reductase and strengthens the activity of carnitine palmitoyltransferase to control the obesity.

Keywords: CPT; Chlorogenic acid; coffee; lipid; medicinal activity; obesity..

Publication types

  • Review

MeSH terms

  • Adenylate Kinase / drug effects
  • Animals
  • Anti-Infective Agents / pharmacology
  • Anti-Infective Agents / therapeutic use
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Anti-Obesity Agents / pharmacology
  • Anti-Obesity Agents / therapeutic use*
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Carnitine O-Palmitoyltransferase / drug effects
  • Chlorogenic Acid / isolation & purification
  • Chlorogenic Acid / pharmacology
  • Chlorogenic Acid / therapeutic use*
  • Coffee / chemistry
  • Drug Evaluation, Preclinical
  • Enzyme Activation / drug effects
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypolipidemic Agents / pharmacology
  • Hypolipidemic Agents / therapeutic use
  • Lipid Metabolism / drug effects
  • Mice
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use
  • Obesity / drug therapy*
  • PPAR alpha / agonists

Substances

  • Anti-Infective Agents
  • Anti-Inflammatory Agents
  • Anti-Obesity Agents
  • Antihypertensive Agents
  • Antioxidants
  • Coffee
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Neuroprotective Agents
  • PPAR alpha
  • Chlorogenic Acid
  • Carnitine O-Palmitoyltransferase
  • Adenylate Kinase